First Command Bank’s Teva Pharmaceuticals TEVA Stock Holding History

First Command Bank’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-765	Closed	-$7K	–	378
2019 Q4	$7K	Hold	765	–	–	﹤0.01%	328
2019 Q3	$5K	Hold	765	–	–	﹤0.01%	351
2019 Q2	$7K	Hold	765	–	–	﹤0.01%	350
2019 Q1	$12K	Hold	765	–	–	0.01%	323
2018 Q4	$12K	Hold	765	–	–	0.01%	327
2018 Q3	$16K	Hold	765	–	–	﹤0.01%	314
2018 Q2	$19K	Sell	765 -155	-17%	-$3.16K	0.01%	301
2018 Q1	$15.7K	Sell	920 -112	-11%	-$2.19K	0.01%	315
2017 Q4	$20K	Sell	1,032 -605	-37%	-$9.1K	0.01%	288
2017 Q3	$29K	Sell	1,637 -191	-10%	-$4.3K	0.02%	248
2017 Q2	$61K	Sell	1,828 -455	-20%	-$14.1K	0.04%	174
2017 Q1	$73K	Buy	2,283 +560	+33%	+$19.1K	0.05%	152
2016 Q4	$62K	Buy	+1,723	New	+$68.8K	0.05%	173

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

First Command Bank's TEVA Position: Q1 2020 in Review

First Command Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 765 shares — an estimated $7K sold.

First Command Bank first reported a position in TEVA in Q4 2016 and held it in 13 quarters. The position peaked at $73K in Q1 2017. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

First Command Bank reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
First Command Bank sold 765 Teva Pharmaceuticals shares in Q1 2020, an estimated $7K.
First Command Bank first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 13 quarters.
First Command Bank's Teva Pharmaceuticals position peaked at $73K in Q1 2017.
459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on First Command Bank's 13F filing for Q1 2020, filed 20 Apr 2020.